Back    Zoom +    Zoom -
<Hindsight>Brokers' Latest TPs/ Opinions on WUXI APPTEC After Quarterly Results
Recommend
2
Positive
1
Negative
0
Broker│ Rating│ Target Price (HKD)
Nomura│Buy│157.07
Morgan Stanley│Overweight│155
JPMorgan│150
Goldman Sachs│ Buy (Conviction List Buy)│149.7
CLSA│ Conviction Outperform│149.3

Broker | Opinion
Nomura | 1Q26 results were strong, an outstanding quarterly results
Morgan Stanley | Share price is expected to rise over the next 30 days on higher earnings forecasts and results guidance
JPMorgan | 1Q25 results beat expectations across the board, with margins widening
Goldman Sachs | Improved operational efficiency drove 1Q26 revenue and earnings well above forecasts; Strong profitability maintained despite foreign exchange headwinds
CLSA | 1Q26 results beat estimations and order intake remained solid, further enhancing visibility into future results

Related NewsBlue Chip WUXI APPTEC (02359.HK) 1Q26 Net Profit Up 26.7% YoY to RMB4.65B


Auto-translated by AI

AASTOCKS Financial News